... ... News & Events ... 16th Annual A-PBA Biorisk Conference Biosafety & Biosecurity - Preparedness for Future Pandemics

07 - 10 November 2023


Eastin Grand Hotel Phayathai, Bangkok, Thailand

Registration Closed

Registration Closed

16th Annual A-PBA Biorisk Conference Biosafety & Biosecurity - Preparedness for Future Pandemics



This regional conference aims at generating a forum exchange on the various current Biosafety and biosecurity issues of concern at the global, regional, national and technical level.

Biosafety and biosecurity are critical components of preparedness for future pandemics. They encompass measures to prevent the accidental release or intentional misuse of dangerous pathogens and to ensure the safe handling and containment of infectious agents. By integrating robust biosafety and biosecurity measures into pandemic preparedness plans, the risks associated with the handling of dangerous pathogens can be minimized, thereby reducing the potential for accidental releases or intentional misuse that could lead to future pandemics.

International biosafety experts and professionals from around the world will be speaking and sharing their knowledge and experiences. This conference will be a valuable opportunity for networking and be updated with the current development on biosafety and biosecurity uniquely to the Asia-Pacific region.

Download the event flyer here.

Conference Highlight

The highlight of the conference is focus on matters concerning future pandemic preparedness.
Co-organiser: Biosafety Association of Thailand (BAT)

Two days Pre-Conference Workshops & two days Conference highlights:
  • Policy, Standard and Guidelines
  • One Health
  • Zoonotic Disease, Emerging and Re-emerging Infectious Disease
  • Emerging Biotechnology
  • Country’s Experience on future pandemic preparedness
  • Pre-conference workshop on:
    • Cybersecurity
    • Biobanking/Biorepository
    • Biosafety risk assessment on biological product manufacturing
    • Biosecurity risk assessment and mitigation
    • Biosafety related standard; 4th LBM WHO
    • Laboratory incident Table Top Exercise (handling, reporting and investigation)
    • Inspection and auditing of Biosafety and Biosecurity for high risk biological materials

Opportunity for networking:
Experience sharing and networking with international biosafety safety experts

Opportunity for exhibition & sponsorship:
Exhibits showcasing the latest in laboratory biosafety and biosecurity products and services

Biosafety Community Coming Together:
A-PBA Annual General Meeting

Who Should Attend

  • Biosafety Professionals and practitioners
  • Researchers and laboratory workers
  • Biosafety Managers & Consultants
  • Engineers and Architects
  • Suppliers and Vendors
  • Professionals interested in updates of biosafety and biosecurity
  • Senior Administrations, Directors and Managers from healthcare industry, educational institutes, veterinary and other industry cluster

Call for Oral/Poster Presentation

The A-PBA Organizing Committee invites submission for oral / poster presentation at the 16th A-PBA Annual Biorisk Conference that will be held from 9th to 10th November 2023. The theme of the conference is: "Preparedness for Future Pandemics"

The following broad topics are the focus for the A-PBA Conference however, papers on other appropriate topics that relate to the goals of the conference will be considered
  • Biosafety / Laboratory Biosafety /Biosecurity / Laboratory Biosecurity
  • Regulatory initiatives impacting biosafety and biosecurity
  • Containment facility design, commissioning, maintenance and operation
  • Biorisk applications related to Infectious diseases affecting humans or animals
  • Containment/laboratory equipment
  • Biological risk assessment / mitigations and communication
  • Applied research and innovations impacting biosafety and biosecurity
The abstract submission deadline is 15th October 2023. Abstracts will be printed in the softcopy conference program booklet.

For more information on poster presentation, please contact our A-PBA secretariat at secretariat@a-pba.org

Guidelines for Submission of Abstract for Oral/Poster Presentation

Each registrant may submit one abstract of his or her presentation during the conference.

Please take note that all abstracts will be reviewed by the scientific committee. They will decide on the final acceptance for either oral or poster presentation for each abstract. All registrants will be advised accordingly by 25th October 2023.

Selected abstracts will ONLY be accepted upon receipt of registration and payment for the conference fee.

  1. All abstracts must be in ENGLISH, the combined length of the abstract title, list of authors, and body should not exceed 300 words. Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. A-PBA does not proofread for correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted.
  2. Title should be brief, in bold capital letters at the top of the abstract.
  3. Author(s) should be listed by surname (underline) and initials, with the presenting author’s name underlined. The designation and organization should immediately follow the authors’ names. (Organization/Institute, department, city, state, country of author).
  4. Text must be typed single-spaced, font 12 Arial with only the left margin justified.
  5. Leave one line between the title/author/institution and the body of the abstract.
  6. Each abstract should contain: (a) an introductory sentence indicating the objective of the abstract (b) main content, including methods and results if relevant and (c) conclusions. It is expected that the abstract will include the summary of the original presentation.
  7. Graphs, tables and illustration cannot be included in the abstract.
  8. The abstract document MUST BE in WORD.doc format. Any other file type WILL NOT be accepted.
  9. Abstracts must be submitted by email to secretariat@a-pba.org as Microsoft Word attachment.
*Note to All Presenters

**The Organizing Committee reserves the right to amend or change any part of the submission guidelines without prior notice.

Conference Registration Rate

Registration Fees Member Non-member
Pre-Conference Workshop (2 full day) S$1000 S$1200
Pre-Conference Workshop (1 full day) S$500 S$600
Conference Registration Fee for Local Participant S$250 S$350
Conference Registration Fee for International Participant S$500 S$600
Networking Dinner (9 November 2023) S$60 S$60

Hotel Venue & Accommodation

The Sikosol Bangkok
477 Si Ayuthaya Road, Thanon Phayathai, Ratchathewi, Bangkok 10400, Thailand
Website: https://www.thesukosol.com/

Hotel Tranz
53 Phayathai Rd., Ratchathewi, Bangkok, Thailand 10400
Website: https://www.hoteltranz.com/

Organizing Committee

Role Personnel
Co-Chair Professor Guizhen Wu
Professor Suda Louisirirotchanakul
Overall Coordinator Dr. Diah Iskandriati
Dr. Martin Moreno
Scientific Committee Professor Guizhen Wu
Dr. Chen Hsing Meng
Dr. Martin Moreno
Professor William Liu Jun
Professor Dr Chonlaphat Sukasem
Professor Srisin Khusmith
Dr. Kobporn Boonnak
Dr. Boonhiang Promdonkoy
Professor Porntippa Lekcharoensuk
Conference Outreach and Sponsorship Promotion Professor Guizhen Wu
Dr Chen Hsing Meng
Professor William Liu Jun
Professor Chonlaphat Sukasem
Professor Srisin Khusmith
Dr. Patravee Soisangwan
Professor Prasert Auewarakul
Conference Logistic Dr. Sau Sokunna
Dr. Chalinee Kongsawat
Kessaya Waidee
Conference Booklet and Website Professor William Liu Jun
A-PBA Secretariat
Accommodation and Hotel Venue Reservation A-PBA Secretariat
Professor Suda Louisirirojanakul
Dr. Patravee Soisangwan
Professor Sirirat Rengpipat
Tippawan Tephassadin
Kunlaya Sukmak
On-Site Registration Dr. Aroem Naroeni
Dr. Hatairat Lerdsamran
Patthana Iamkrasin
Dr. Chaisuree Supavilai
Namol Vorapreeda
Dr. Charinee Kongsawat
Tippawan Tephassadin
Professor Porntippa Lekcharoensuk
Exhibitor Sponsorship and Exhibition Dr Sau Sokunna
Professor William Liu Jun
Professor Dr. Lim Yang Mooi
Reception (Opening ceremony and Dinner) Dr. Diah Iskandriati
Dr. Chaisuree Supavilai
Namol Vorapreeda
Dr. Charinee Kongsawat
Tippawan Tephassadin

Pre-Conference Workshop

Day 1 – Tuesday, 7 November 2023

TimeWorkshop 1 (Room 1) Workshop 2 (Room 2) Workshop 3 (Room 3)
09.00 - 17.00 Topic:
Fundamentals of Biorisk Management Systems using ISO 35001
Biosafety risk assessment on biological product manufacturing
Dr. Rodel Janathan S. Vitor II
De La Salle University
Dr Mok Chee Keng
A*STAR Infectious Disease Labs, Singapore
Dr HM Chen
Intelligent-Bio Co., Ltd.
12.30 – 14.00 LUNCH

Day 2 – Wednesday, 8 November 2023

TimeWorkshop 4 (Room 1) Workshop 5 (Room 2) Workshop 6 (Room 3)
09.00 - 17.00 Topic:
Biobanking / Biorepository
Biosecurity Risk Assessment and Mitigation
Inspection and auditing of Biosafety and Biosecurity for high risk biological materials
Dr. Qiang Wei
Dr. Jing Li

Laboratory Management Office, Chinese Center for Disease Control and Prevention (China CDC) Beijing, China
Mr David Lam
Singapore General Hospital
Dr. Peipei Liu
Dr. Juan Song
Dr. Xuexin Hou

Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) Beijing, China
12.30 – 14.00 LUNCH

Conference Program

Day 1 – Thursday, 9 November 2023

Time Program
08.00 – 09.00 Registration
Membership renewal and registration
Welcome and Opening
09.00 – 09.20 Welcome and Opening Remarks Professor Guizhen Wu (A-PBA)

Professor Suda Louisirirotchanakul (BAT)
09.20 – 09.40 Opening Address by Guest of Honor Permanent Secretary,
Ministry of Public Health, Thailand
09.40 – 10:00 Group Photo
10.00 – 10.30 Coffee/Tea Break/ Poster Exhibition/Commercial Exhibition
Time Program Speaker
Session 1
Policy, Standard, Guidelines
Chairperson: Dr Chen HM and Prof Srisin Khusmith
10.30 – 11.00 Keynote (hybrid) Kazunobu Kojima
MD, PhD, World Health Organization
11.10 – 11.20 Implementation of Biosafety and Biosecurity Policies and Guidelines through Partner Capacity-Building Programs Dr. Julia Scordo
11.20 – 11.40 Challenges and Practices in Building and Implementing Biosafety and Biosecurity Laws in Thailand Dr. Patravee Soisangwan
Bureau of Laboratory Quality Standards
11.40 – 12.00 Standards and Guidelines: Elements that Help Shape (Bio)Safety Culture Mr David Lam, BA
Singapore General Hospital
12.00 – 13.30 Poster Exhibition/Commercial Exhibition
Lunch Break
Session 2
One Health
Chairperson: Dr Aroem Naroeni and Prof Prasert Auewarakul
13.30 – 13.50 Role of One Health University Network in Supporting the Government for the Implementation of Laboratory Biorisk Management System: Lessons Learned from Indonesia Case Dr Joko Pamungkas
Indonesia One Health University Network (INDOHUN), Indonesia
13.50 – 14.10 Ensuring Biosafety and Biosecurity: A Training Curriculum Prof Zunita Zakaria
Malaysia One Health University Network (MyOHUN) UPM, Malaysia
14.10 – 14.30 Invited speaker 6 Dr Scott Newman
Animal Production and Health Commission for Asia and Pacific (APHCA) Secretary and One Health Regional Program Priority Lead
14.30 – 14.50 Biological Threat Reduction Program Vietnam Building Capacity on Biorisk Management, 2017-2023 Dr Phuc Pham Duc
Vietnam One Health University Network (VOHUN), Hanoi, Vietnam
14.50– 15.30 Coffee/Tea Break/ Poster Exhibition/Commercial Exhibition
Session 3
Zoonotic Disease
Chairperson: Dr Diah Iskandriati and Prof Pornthipa Lekcharoensuk
15.30 – 15.50 Invited speaker 8 Prof. Guoqing Wang
College of Basic Medicine, Jilin University, China
15.50 – 16.10 Zoonotic Diseases with Pandemic Potential in 2023: Biosafety and Biosecurity Perspectives Dr Asadulghani
CBangladesh Biosafety and Biosecurity Society Bangladesh
16.10 – 16.30 One health approach for control of zoonotic diseases Assoc. Prof. Parnthep Ratanakorn
Thailand Association for Laboratory Animal Science (TALAS)
16.30 – 16.50 Invited speaker 11 Syafrison Idris
DVM, MSi Directorat of Animal Health, Ministry of Agriculture, Indonesia
17.00 – 19.00 A-PBA Annual General Meeting
19.00 – 21.00 Networking Dinner
(A-PBA EXCO, speakers, co-host, invited guests)

Day 2 – Friday, 10 November 2023

Time Program Speaker
Session 4
Emerging and Re-emerging Infectious Disease
Chairperson: Prof William Jin Liu and Prof Suda Louisirirotchanakul
09.00 – 09.20 Biosafety from a global perspective in the post-COVID-19 era Prof. Guizhen Wu
National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing, China
09.20 – 09.40 Invited speaker 13 Dr. Peter Daszak
EcoHealth Alliance, USA
09.40 – 10.00 Invited speaker 14 Prof. Dr. Prasert Auewarakul
Faculty of Medicine Siriraj Hospital
10.00 – 10.20 Roles of laboratory animals in Emerging Infectious Disease Research Richard Kelly, DVM
Armed Forces Research Institute of Medical Sciences (AFRIMS) Bangkok
10.20 – 10.50 Coffee/Tea Break/ Poster Exhibition/Commercial Exhibition
Session 5
Emerging Biotechnology
Chairperson: Prof Dr Lim Yang Mooi & Dr Boonhiang Promdonkoy
10.50– 11.10 Invited speaker 16 Prof. Hua Gu
Hangzhou Institute of Medicine, Chinese Academy of Sciences
11.10 – 11.30 Chimeric Antigen Receptor (CAR) T cell against CD19 in Cancer Immunotherapy Assoc. Prof. Dr. Usanarat Anurathapan
Ramathibodi Hospital
11.30 – 11.50 Institutional Oversight of Emerging Biotechnologies Dr. Prasad Kuduvalli
Health Security Partners, USA
11.50– 12.10 Dual-use research of concern in advanced biotechnology Professor Herawati Sudoyo
Indonesian Academic of Science
12.10 – 13.30 Poster Exhibition/Commercial Exhibition
Lunch Break
Session 6
Country Experience Sharing
Chairperson: Dr Sau Sokunna and Prof Sirirat Rengpipat
13.30 – 13.50 Tips on Designing a Modern High Containment (BSL-3) Laboratory Dr. Mok Chee Keng
A*STAR Infectious Disease Labs, Singapore
13.50 – 14.10 Addressing Emerging Biorisks and Future Pandemics: The Philippine Experience Prof. Oliver Shane R. Dumaoal
BRAP, Philippines
14.10 – 14.30 Biosafety and Biosecurity in Sri Lanka - Preparing for future pandemics Dr. Roshan Jayasuriya
National Institute of Health Sciences, Sri Lanka
14.30 – 14.50 How to prepare responding plan for biosafety incident in BSL-2/BSL-3 Laboratory in Taiwan Dr. Chen HM
Taiwan Biosafety Association, Taipei, China
14.50 – 15.10 Assessment of Covid-19 Damages on Human Life and Key Correlating Factor Prof Lee Hei Chan
Sun Moon University, South Korea
15.10– 15.30 Coffee / Tea Break/Poster Exhibition/Commercial Exhibition
Session 7
Open Paper
Chairperson: Dr Martin Moreno and Prof William Jin Liu
15.30 – 15.50 Invited speaker 25 Tianjin Changte Purification Technology Co,Ltd. China
15.50 – 16.10 Women’s Network for Biosafety & Biosecurity Maureen Ellis
16.10 – 16.30 Evolution of Biosafety and Biosecurity Initiatives in Tanzania: From Assessment to Multisectoral Action Dr. Zachariah E. Makondo and Dr. Ndekya M. Oriyo
Tanzanian Biological Safety Association
16.30 – 16.50 Invited speaker 28 Beijing Huironghe Technology Co., Ltd., China
16.50– 17.00 Poster Award Presentation
Closing Remark


The Name of the Company Type

Tianjin Changte Purification Technology Co,Ltd

天津昌特净化科技有限公司成立于 2001 年,主要以生物安全关键防护装备 为主营业务,集研发、生产、工程施工、设施运维、生物安全咨询为一体的高新 技术企业,多年来公司一直致力于国家生物安全防护事业的发展,参与并完成多 项国家级科技专项课题,获得专利 60 余项。公司研制了袋进袋出高效过滤单元、 风口式高效过滤装置、密闭门、 化淋系统、头罩熏蒸舱、猴隔离器等 20 多类 生物安全关键防护装备,广泛应用于高等级安全生物实验室。
Tianjin Changte Purification Technology Co., Ltd. was established in 2001, mainly focusing on biosafety critical protective equipment. It is a high-tech enterprise that integrates research and development, production, engineering construction, facility operation and maintenance, and biosafety consulting. For many years, the company has been committed to the development of national biosafety protection, participated in and completed multiple national level scientific and technological special projects, and obtained more than 60 patents. The company has developed over 20 types of biosafety critical protective equipment, including bag in and bag out high-efficiency filtration units, vent type high-efficiency filtration devices, closed doors, chemical shower systems, hood fumigation chambers, monkey isolators, etc., which are widely used in high-level safety biological laboratories.

Download the company profile here

Beijing Huironghe Technology Co., Ltd

Founded in 2010, Beijing Huironghe Technology Co., Ltd. is located at Zhongguancun Science and Technology Park, Tongzhou District, Beijing, specializes in R&D, production, sales and technical services of inhalation toxicology, genetic toxicology, aerosol detection and other laboratory instruments.

With more than 3000sqm of office, R&D center and workshop, the company has passed ISO9001:2015 Quality Management System, ISO14001:2015 Environmental Management System, ISO45001:2018 Occupational Health Management System and GB/T29490-2013 Intellectual Property Management System.

More than 60 instruments were invented including aerosol, inhalation instrument, fully Automated QuEChERS system, NGI, breathing simulator etc. Aerosol toxicology instruments cover a full range of instruments for rats, mice, guinea pigs, ferrets, rabbits, dogs and monkeys. Exposure methods include nose-only inhalation exposure, systemic exposure, spreading infection and in vitro cell exposure, etc. All products of aerosol generation, aerosol detection, aerosol sampling and system control are independent intellectual properties. Our products are widely used in GLP laboratories, safety assessment centers, Universities, scientific research institutions and respiratory dept. of hospitals, etc. The domestic market share of inhalation toxicology instruments applied in GLP laboratories exceeded 90% in the past three years, and the comprehensive market share exceeded 70%.

Download the company profile here
Refer to our website for the info here

Chongqing Zhifei Biological Products Co., Ltd.

Chongqing Zhifei Biological Products Co., Ltd.(Named Zhifei) has its presence in biological product industry in 2002, integrating the R&D, production, marketing, distribution as well as import & export of human vaccine.

Zhifei was listed on the Shenzhen Stock Exchange in 2010, becoming the first privately-run vaccine enterprise listed on ChiNext. Zhifei also invested into biological area, focusing on antibody products, diabetes products, Car-T therapy.

The commercially available products include Recombinant Novel Coronavirus Vaccine (CHO Cell),Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) , Haemophilus Influenzae Type b Vaccine, Group ACYW135 Meningococcal Polysaccharide Vaccine, Mycobacterium Vaccae for Injection, Meningococcal Group A and Group C Polysaccharide Conjugate Vaccine, and other independently developed products.

Refer to our website for the info here
Download the company profile here
Watch company profile here
Beijing Wantai Biological Pharmacy Co., Ltd.

Watch company profile here
China Electronics System Engineering

Shanghai Origincell Biological Cryo Equipment Co., Ltd.

Origincell specializes in cutting edge R&D and manufacturing of intelligent and fully automatic cryogenic biobanking systems. Our highly skilled team consists of a diverse group of scientists and engineers from various disciplines.With exceptional expertise in cryopreservation and automation technologies, Origincell offers comprehensive and one stop solution of intelligent biostorage systems.

Refer to our website for the info here

Beijing Yi’an Yatai Biotechnology Co

Beijing Yi'an Asia-Pacific Biotechnology Co., Ltd. has been deeply engaged in the field of biological-Protection for 20 years, specializing in the design, R&D, production BSL-2/3/4 protective equipment. We have a strict product quality control system to provide you with the excellent biosafety protection. We hope to be your ideal partner!

Refer to our website for the info here
Shenzhen Smart Intelligence Technology Co., Ltd

Haier Biomedical HK Co. Limited

SGS Vitrology Limited, UK

With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products.

SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
Beijing Biological Products Institute

Download the company profile here

i-Lab Engineering Pte Ltd , Singapore

Refer to our website for the info here

Beijing Goldfield Medical Devices

Beijing Gofeld Medical Device Co., Ltd. was established in 2011 with a registered capital of 4.7 million yuan and has obtained legal business licenses for Class II and Class III medical devices. The company's main products include Class III: 6815 injection puncture instruments, 6821 medical electronic instruments and equipment, 6822 medical optical instruments, instruments and endoscope equipment, 6823 medical ultrasound instruments and related equipment, 6824 medical laser instruments and equipment, 6830 medical X-ray equipment, 6840 clinical laboratory analyzers and diagnostic reagents (including diagnostic reagents), 6854 operating room, emergency room, diagnosis and treatment room equipment and equipment, 6866 medical polymer materials and products, etc.

Since its establishment, the company has had good cooperation with major hospitals in Beijing, Hebei Government Procurement Center, China Center for Disease Control and Prevention, Beijing Center for Disease Control and Prevention, and some hospitals in Hebei.

Download the company profile here

Survey & Certificate

Complete the survey and get your certificate

Contact Icon